Use of antibacterials in the management of symptoms of acute respiratory tract infections among children under five years in Gulu, northern Uganda: Prevalence and determinants

PLoS One. 2020 Jun 23;15(6):e0235164. doi: 10.1371/journal.pone.0235164. eCollection 2020.

Abstract

Inappropriate use of antibacterials is a major public health challenge as it can promote emergence of resistance, wastage of financial resources, morbidity and mortality. In this study, we determined the prevalence and factors associated with antibacterial use in managing symptoms of acute respiratory tract infections (ARIs) in households in rural communities of Gulu district, northern Uganda. A cross-sectional study was conducted among households selected using multi-stage sampling. Data were collected through interviews with care-givers of children under five years, using a structured interviewer administered questionnaire. Out of the 856 children who had symptoms of ARIs, 515 (60.2%; CI: 54.5%-65.6%) were treated with antibacterials. The most commonly used antibacterials were amoxicillin (55.2%, n = 358), cotrimoxazole (15.4%, n = 100) and metronidazole (11.4%, n = 74). The determinants of antibacterial use included; getting treatment from a health facility (AOR: 1.85, CI: 1.34-2.56, P < 0.001), households located in peri-urban area (AOR: 2.54, CI: 1.34-4.84, P = 0.005), and a child having cough (AOR: 7.02, CI: 4.36-11.31, P < 0.001). The prevalence of antibacterial use among children under five years with symptoms of ARIs is high in communities of Gulu district, northern Uganda. Getting treatment from a health facility, if a household was located in a peri-urban area and having a cough are positive predictors of antibacterial use. There is need for targeted education on appropriate antibacterial use in rural communities and hospital settings where over prescription is most likely especially in treating symptoms of ARIs among children under five years.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Child, Preschool
  • Cough / complications
  • Cough / diagnosis
  • Cough / drug therapy
  • Cross-Sectional Studies
  • Female
  • Health Surveys / methods
  • Health Surveys / statistics & numerical data
  • Humans
  • Infant
  • Logistic Models
  • Male
  • Metronidazole / therapeutic use
  • Multivariate Analysis
  • Prevalence
  • Respiratory Tract Infections / complications
  • Respiratory Tract Infections / diagnosis
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / epidemiology
  • Risk Factors
  • Rural Health Services / statistics & numerical data*
  • Rural Population / statistics & numerical data*
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
  • Uganda / epidemiology

Substances

  • Anti-Bacterial Agents
  • Metronidazole
  • Amoxicillin
  • Trimethoprim, Sulfamethoxazole Drug Combination

Associated data

  • Dryad/10.5061/dryad.ghx3ffbjj

Grants and funding

Makerere University -SIDA collaboration (Sida PI0010) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.